Carregant...
Comparison of topical tofacitinib and 0.1% hypochlorous acid in a murine atopic dermatitis model
BACKGROUND: Topical administration of PR022, 0.05% hypochlorous acid (HOCl) in gel has been demonstrated to be beneficial in a chronic murine atopic dermatitis model. In a follow up study we tested a higher concentration (0.1%) of PR022 HOCl gel in comparison to the Janus kinase inhibitor tofacitini...
Guardat en:
| Publicat a: | BMC Pharmacol Toxicol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6029395/ https://ncbi.nlm.nih.gov/pubmed/29970189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-018-0232-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|